Simulations Plus News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.01.24	Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant (Businesswire)
03.01.24	Simulations Plus: Q1 Earnings Insights (Benzinga)
03.01.24	Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth (Businesswire)
02.01.24	Earnings Preview: Simulations Plus (Benzinga)
20.12.23	Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date (Businesswire)
14.11.23	Simulations Plus Outlines Paths to Win at 2023 Investor Day (Businesswire)
08.11.23	ISoP New Board of Trustees Members Announced (Businesswire)
31.10.23	Simulations Plus to Host Investor Day on Tuesday, November 14th (Businesswire)
24.10.23	Ausblick: Simulations Plus stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
11.10.23	Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call (Businesswire)
21.09.23	Simulations Plus Receives New FDA Grant Award (Businesswire)
07.09.23	Simulations Plus Hosts First-of-its-Kind Virtual Summer Camp for Students and Professors (Businesswire)
24.08.23	Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS) (Businesswire)
15.08.23	Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment (Businesswire)
13.07.23	Simulations Plus Releases ADMET Predictor® 11 (Businesswire)
05.07.23	Ausblick: Simulations Plus stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
22.06.23	Erste Schätzungen: Simulations Plus öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
21.06.23	Simulations Plus Announces Third Quarter Fiscal Year 2023 Earnings and Conference Call Date (Businesswire)
20.06.23	Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities (Businesswire)
10.05.23	Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes (Businesswire)
18.04.23	Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses (Businesswire)
04.04.23	Ausblick: Simulations Plus legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
30.03.23	MIDD+ 2023 Panelists Discuss How to Increase Gender Equity for Women in Science (Businesswire)
28.03.23	Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology (Businesswire)
22.03.23	Erste Schätzungen: Simulations Plus informiert über die jüngsten Quartalsergebnisse (finanzen.net)
21.03.23	Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call (Businesswire)
16.03.23	Simulations Plus to Present at Sidoti March Small-Cap Conference (Businesswire)
15.03.23	Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds (Businesswire)
09.03.23	Lixoft Adds New Data Formatting and Reporting Modules to MonolixSuite™ in Version 2023R1 (Businesswire)
07.03.23	Simulations Plus to Present at Oppenheimer 33rd Annual Healthcare Conference (Businesswire)
28.02.23	Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference (Businesswire)
16.02.23	Simulations Plus and Global Agrochemicals Leader to Collaborate on Machine Learning Models (Businesswire)
09.02.23	Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool (Businesswire)
12.01.23	Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure (Businesswire)
12.01.23	Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement (Businesswire)
05.01.23	Pre-market Movers: OBLG, HKD, NUWE, RNER, ARCK… (RTTNews)
04.01.23	Simulations Plus Reports First Quarter Fiscal 2023 Financial Results (Businesswire)
03.01.23	Ausblick: Simulations Plus mit Zahlen zum abgelaufenen Quartal (finanzen.net)
21.12.22	Erste Schätzungen: Simulations Plus stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
19.12.22	Simulations Plus Sets Date for First Quarter Fiscal Year 2023 Earnings Release and Conference Call (Businesswire)
15.11.22	Simulations Plus and the University of Bath Awarded New FDA Grant (Businesswire)
10.11.22	Gustavo Mendes Lima Santos Joins the Simulations Plus Regulatory Fellowship Program (Businesswire)
03.11.22	Simulations Plus 25th Anniversary Celebration Concludes with $25,000 Gift to Nonprofit, Girls Who Code (Businesswire)
02.11.22	Simulations Plus and the University of Florida Awarded New FDA Contract to Support Development and Regulatory Assessment of Inhaled Products (Businesswire)
25.10.22	Ausblick: Simulations Plus stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
20.10.22	Simulations Plus Announces Cash Dividend (Businesswire)
12.10.22	Simulations Plus Releases GastroPlus® Version 9.8.3 (Businesswire)
12.10.22	Erste Schätzungen: Simulations Plus legt Quartalsergebnis vor (finanzen.net)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V

Nachrichten zu Simulations Plus IncShs

Aktien Top/Flop

Meistgelesene Nachrichten